Exagen Inc. (XGN) NASDAQ

7.14

+0.19(+2.73%)

Updated at June 02 04:00PM

Currency In USD

Valuation

Market Cap74.63M
Enterprise Value75.6M
P/E Ratio-8.54
PEG Ratio7.09
Price/Sales Ratio2.75
Price/Book Ratio20.69
Enterprise/Revenue2.64
Enterprise/EBITDA-12.33

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.27
Operating Margin-0.25

Management Effectiveness

Return On Assets-0.38
Return On Equity-1.34

Income Statement

Revenue55.64M
Revenue/Share3.06
Gross Profit33.11M
EBITDA-11.15M
Net Income-15.12M
Diluted EPS-0.83

Balance Sheet

Total Cash11.19M
Total Cash/Share0.6
Total Debt5.03M
Total Debt/Equity0.79
Current Ratio2.32
Book Value Per Share0.35

Price History

52-Week Change262.44
52-Week High7.23
52-Week Low1.71
Moving Average 50 Days5.29
Moving Average 200 Days3.96

Statistics

Average Volume202,756
Shares Outstanding21.85M
% Held by Institutions33.61

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A